- Home
- News
- Topics
- FDA Week
- Inside CMS
- Inside Drug Pricing
- Health Exchange Alert
- Inside TeleHealth
- About Us
/index.php?option=com_iwpfile&file=/dir_01/he2002_2593.pdf
FOR IMMEDIATE RELEASE:
Wednesday, October 9, 2002
CONTACT:
Ken Johnson or Vikki Riley
202.225.5735
Tauzin Delivers Statement
On Generic Drug Competition
WASHINGTON (October 9) -- House Energy and Commerce Committee Chairman Billy Tauzin (R-LA) is scheduled to deliver the following remarks today at a Health subcommittee hearing on generic drug competition:
ts
FOR IMMEDIATE RELEASE
P02-41
October 8, 2002
Media Inquiries: 301-827-6242
Consumer Inquiries: 888-INFO-FDA
SECRETARY THOMPSON URGES STRONG WARNING LABELS FOR EPHEDRA
FDA To Propose Good Manufacturing Practices Regulations For Dietary Supplements
HHS Secretary Tommy G. Thompson today announced that he has asked the Food and Drug Administration (FDA) to evaluate the best scientific evidence available and recommend the strongest possible mandatory warning label possible for ephedra products.
re
For Release: Immediately
Contact: HHS Press Office
(202) 690-6343
HHS ESTABLISHES FIRST PHASE OF MEDICAL TRAINING PROGRAM TO PROVIDE HEALTH CARE ASSISTANCE IN AFGHANISTAN
Update: Listeriosis Outbreak Investigation
Update October 8, 2002 Contact: CDC, Media Relations (404) 639"3286
have been detected; all were hospitalized, 7 died, and 3 pregnant women had miscarriages or stillbirths. These patients live in 7 states: Pennsylvania (14 cases), New York (11 cases in New York City, 6 in other locations), New Jersey (4 cases), Delaware (4 cases), Maryland (2 cases), Connecticut (1 case), and Michigan (1 case).
/index.php?option=com_iwpfile&file=/dir_01/he2002_2587.pdf